These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994 [TBL] [Abstract][Full Text] [Related]
3. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors. Jamieson S; Alexiadis M; Fuller PJ Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971 [TBL] [Abstract][Full Text] [Related]
4. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531 [TBL] [Abstract][Full Text] [Related]
5. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization and mRNA expression of activin, inhibin, follistatin, and activin receptor in bovine cumulus-oocyte complexes during in vitro maturation. Izadyar F; Dijkstra G; Van Tol HT; Van den Eijnden-van Raaij AJ; Van den Hurk R; Colenbrander B; Bevers MM Mol Reprod Dev; 1998 Feb; 49(2):186-95. PubMed ID: 9444661 [TBL] [Abstract][Full Text] [Related]
7. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gurusinghe CJ; Healy DL; Jobling T; Mamers P; Burger HG Gynecol Oncol; 1995 Apr; 57(1):27-32. PubMed ID: 7705698 [TBL] [Abstract][Full Text] [Related]
8. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry. Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865 [TBL] [Abstract][Full Text] [Related]
9. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. Roberts VJ; Barth S; el-Roeiy A; Yen SS J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340 [TBL] [Abstract][Full Text] [Related]
10. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the villous tissue of miscarriage patients. Muttukrishna S; Bearfield C; Johns J; Jauniaux E Mol Hum Reprod; 2004 Nov; 10(11):793-8. PubMed ID: 15361555 [TBL] [Abstract][Full Text] [Related]
11. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle. Lovell TM; Knight PG; Gladwell RT J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664 [TBL] [Abstract][Full Text] [Related]
12. Seladin-1/DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours. Fuller PJ; Alexiadis M; Jobling T; McNeilage J Clin Endocrinol (Oxf); 2005 Jul; 63(1):111-5. PubMed ID: 15963070 [TBL] [Abstract][Full Text] [Related]
13. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. Roberts VJ; Barth S; el-Roeiy A; Yen SS J Clin Endocrinol Metab; 1993 Nov; 77(5):1402-10. PubMed ID: 8077341 [TBL] [Abstract][Full Text] [Related]
14. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells. Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249 [TBL] [Abstract][Full Text] [Related]
15. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells. Erämaa M; Hildén K; Tuuri T; Ritvos O Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658 [TBL] [Abstract][Full Text] [Related]
16. [Expression pattern of mRNA for follistatin and inhibin/activin beta B-subunit during follicular and testicular development in duck]. Fu Y; Niu D; Ruan H; Yu XP; Chen G; He GQ; Yang PX Yi Chuan Xue Bao; 2001; 28(9):808-15. PubMed ID: 11582738 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of activin-beta A subunit mRNA is associated with decreased activin type II receptor mRNA levels in the testes of alpha-inhibin deficient mice. Trudeau VL; Matzuk MM; Haché RJ; Renaud LP Biochem Biophys Res Commun; 1994 Aug; 203(1):105-12. PubMed ID: 8074643 [TBL] [Abstract][Full Text] [Related]
19. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids. Alexander JM; Swearingen B; Tindall GT; Klibanski A J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603 [TBL] [Abstract][Full Text] [Related]
20. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues. van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]